Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Sequoia Capital
MedTech
Virtue Diagnostics nets $100M for affordable in vitro testing
Virtue may be its own reward, but for Virtue Diagnostics, at least, a fresh infusion of venture capital is a close second.
Andrea Park
Jan 6, 2022 10:10am
Metis debuts with $86M to bankroll 2022 trial, gene therapy push
Dec 7, 2021 6:00am
China's Stemirna raises $188M to fund mRNA COVID-19 vaccine
Jun 4, 2021 8:25am
Digital health coach Noom nets $540M to tackle diabetes and more
May 25, 2021 11:25am
Benchling makes the A-team with $200M Series E
Apr 14, 2021 11:36am
Illumina, Sequoia Capital launch genomics incubator in China
Feb 1, 2021 10:22am
